Lymphocytosis - 15 Studies Found Not yet recruiting : Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma : Anemia B-Cell Prolymphocytic Leukemia Fatigue : 2017-01-03 : Drug: Entospletinib Given PO Active, not recruiting : Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma : Anemia Chronic Lymphocytic Leukemia Fatigue : 2014-01-27 : Drug: Cyclophosphamide Given I Recruiting : CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant : Chronic Myeloid Leukemia (CML) Acute Myelogenous Leukemia (AML); Device: CliniMACS CD34+ Reagent System Recruiting : Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome : Monoclonal Gammopathy of Undetermined Significance (MGUS) Chronic Lymphocytic Leukemia (CLL) : 2014-10-09 Recruiting : Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia : Lymphoproliferative Disorders : 2006-06-27 : Drug: Alemtuzumab (Campath) <<< Previous